OSR Holdings, Inc. (OSRH) presents a deeply negative liquidation posture as of March 31, 2026. The MFFAIS-derived cash liquidation value of approximately -$15.5 million confirms that, under a stop-and-liquidate scenario, equity holders receive nothing after liabilities are settled at face value. The balance sheet is dominated by non-recoverable intangible assets: patent technology alone carries a net book value of $138.8 million (gross $166.3 million, accumulated amortization $27.6 million), and total net intangibles stand at $139.0 million against total consolidated assets. Under the liquidation lens, intangibles are written to zero, eliminating the majority of the asset base. Goodwill increased from $24.9 million at December 31, 2025 to $29.7 million at March 31, 2026, driven by the Q1 2026 acquisition of Woori IO Co., Ltd. for $10.5 million in OSR equity (84,338 shares at $124/share). Woori IO contributed $6.4 million of new goodwill and brought with it $1.47 million in acquired liabilities against only $394 thousand in identifiable assets, meaning the entity was net-liability at acquisition. Goodwill is zero-recovery under the liquidation lens, so this transaction added net negative liquidation value. PP&E net book value is minimal at $153 thousand and would recover approximately $77-107 thousand at a 50-70% haircut. Cash reported at approximately $1.57 million (per MD&A) represents the primary tangible recovery anchor. Short-term borrowings aggregate approximately $4.4 million across multiple lenders (BCM Europe AG $860K, BGLSI $1.21M, individual borrowers $1.43M, Duksung $650K, Korean institutional lenders ~$231K), all due in 2026. Long-term debt is approximately $272 thousand. A White Lion Capital convertible note (par $1.11 million, 5% rate, variable conversion at 95% of 15-day VWAP) adds an additional liability and dilution overhang; this instrument is classified as a short-term borrowing. Post-balance-sheet, a $1.055 million senior secured convertible note was issued to White Lion on April 7, 2026, secured by substantially all company assets — this lien materially affects recovery priority in a liquidation scenario but is not reflected in the March 31 balance sheet. An $815 million milestone payment arrangement under the April 29, 2026 VXM01 Global Exclusive License Agreement with BCM Europe AG is discussed extensively in MD&A and subsequent events but carries no balance sheet recognition and represents contingent future cash, not a liquidation-date asset. The filing discloses unremediated material weaknesses in internal controls related to completeness and accuracy of liabilities, which introduces additional uncertainty regarding whether all liabilities are fully reflected. Accumulated deficit was approximately $40.1 million as of March 31, 2026. The filing does not separately tag total assets, total liabilities, or stockholders' equity in XBRL within the TAG_CONTEXT provided, which limits tag-level analysis; key balance sheet aggregates are referenced in MD&A narrative only.
▼ Community Notes